<bill session="115" type="h" number="1409" updated="2017-07-12T07:16:20Z">
  <state datetime="2017-03-07">REFERRED</state>
  <status>
    <introduced datetime="2017-03-07"/>
  </status>
  <introduced datetime="2017-03-07"/>
  <titles>
    <title type="short" as="introduced">Cancer Drug Parity Act of 2017</title>
    <title type="short" as="introduced">Cancer Drug Parity Act of 2017</title>
    <title type="official" as="introduced">To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for cost sharing for oral anticancer drugs on terms no less favorable than the cost sharing provided for anticancer medications administered by a health care provider.</title>
    <title type="display">Cancer Drug Parity Act of 2017</title>
  </titles>
  <sponsor id="412290"/>
  <cosponsors>
    <cosponsor id="412713" joined="2017-05-03"/>
    <cosponsor id="412683" joined="2017-04-25"/>
    <cosponsor id="412250" joined="2017-05-17"/>
    <cosponsor id="412635" joined="2017-06-06"/>
    <cosponsor id="400032" joined="2017-03-07"/>
    <cosponsor id="400033" joined="2017-03-22"/>
    <cosponsor id="412501" joined="2017-05-03"/>
    <cosponsor id="412652" joined="2017-04-25"/>
    <cosponsor id="412539" joined="2017-07-11"/>
    <cosponsor id="412537" joined="2017-05-17"/>
    <cosponsor id="412622" joined="2017-03-07"/>
    <cosponsor id="412571" joined="2017-04-25"/>
    <cosponsor id="412600" joined="2017-03-07"/>
    <cosponsor id="412271" joined="2017-05-17"/>
    <cosponsor id="412658" joined="2017-03-07"/>
    <cosponsor id="412555" joined="2017-04-25"/>
    <cosponsor id="400090" joined="2017-03-07"/>
    <cosponsor id="412536" joined="2017-05-22"/>
    <cosponsor id="400100" joined="2017-03-07"/>
    <cosponsor id="400103" joined="2017-05-22"/>
    <cosponsor id="400648" joined="2017-06-06"/>
    <cosponsor id="412477" joined="2017-03-13"/>
    <cosponsor id="412672" joined="2017-03-07"/>
    <cosponsor id="412480" joined="2017-03-07"/>
    <cosponsor id="400640" joined="2017-03-20"/>
    <cosponsor id="412257" joined="2017-03-07"/>
    <cosponsor id="412529" joined="2017-06-27"/>
    <cosponsor id="400142" joined="2017-05-03"/>
    <cosponsor id="412612" joined="2017-03-27"/>
    <cosponsor id="412382" joined="2017-03-07"/>
    <cosponsor id="412485" joined="2017-03-20"/>
    <cosponsor id="400162" joined="2017-03-13"/>
    <cosponsor id="412278" joined="2017-03-07"/>
    <cosponsor id="400163" joined="2017-05-03"/>
    <cosponsor id="412280" joined="2017-03-07"/>
    <cosponsor id="400170" joined="2017-06-06"/>
    <cosponsor id="400641" joined="2017-03-07"/>
    <cosponsor id="412550" joined="2017-06-27"/>
    <cosponsor id="412511" joined="2017-07-11"/>
    <cosponsor id="412460" joined="2017-04-25"/>
    <cosponsor id="412673" joined="2017-05-17"/>
    <cosponsor id="412543" joined="2017-03-22"/>
    <cosponsor id="412546" joined="2017-03-07"/>
    <cosponsor id="412583" joined="2017-03-07"/>
    <cosponsor id="400219" joined="2017-03-07"/>
    <cosponsor id="400230" joined="2017-05-03"/>
    <cosponsor id="412256" joined="2017-03-07"/>
    <cosponsor id="400240" joined="2017-06-06"/>
    <cosponsor id="400630" joined="2017-06-06"/>
    <cosponsor id="400245" joined="2017-04-25"/>
    <cosponsor id="412445" joined="2017-03-07"/>
    <cosponsor id="412293" joined="2017-05-22"/>
    <cosponsor id="412643" joined="2017-03-07"/>
    <cosponsor id="412562" joined="2017-03-07"/>
    <cosponsor id="412698" joined="2017-06-06"/>
    <cosponsor id="400654" joined="2017-05-22"/>
    <cosponsor id="400259" joined="2017-05-17"/>
    <cosponsor id="412487" joined="2017-03-22"/>
    <cosponsor id="412710" joined="2017-07-11"/>
    <cosponsor id="412632" joined="2017-04-25"/>
    <cosponsor id="400285" joined="2017-03-07"/>
    <cosponsor id="412443" joined="2017-04-25"/>
    <cosponsor id="412523" joined="2017-03-20"/>
    <cosponsor id="412307" joined="2017-03-07"/>
    <cosponsor id="412585" joined="2017-03-07"/>
    <cosponsor id="400652" joined="2017-03-07"/>
    <cosponsor id="400326" joined="2017-05-17"/>
    <cosponsor id="400352" joined="2017-03-07"/>
    <cosponsor id="412212" joined="2017-05-17"/>
    <cosponsor id="400365" joined="2017-03-20"/>
    <cosponsor id="400367" joined="2017-03-07"/>
    <cosponsor id="400378" joined="2017-07-11"/>
    <cosponsor id="412722" joined="2017-04-25"/>
    <cosponsor id="412259" joined="2017-03-13"/>
    <cosponsor id="412514" joined="2017-03-07"/>
    <cosponsor id="400623" joined="2017-03-07"/>
    <cosponsor id="412255" joined="2017-03-07"/>
    <cosponsor id="412211" joined="2017-04-03"/>
    <cosponsor id="412430" joined="2017-05-17"/>
    <cosponsor id="412628" joined="2017-04-25"/>
  </cosponsors>
  <actions>
    <action datetime="2017-03-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-03-07" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-03-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Drug therapy"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2017-03-07T05:00:00Z" status="Introduced in House">Cancer Drug Coverage Act of 2017

This bill amends the Public Health Service Act to require group and individual health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medication approved by the Food and Drug Administration that is prescribed based on a finding by the treating physician that the medication is medically necessary for cancer treatment and is clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with this requirement, health plans may not, for anticancer medications: (1) change or replace benefits to increase out-of-pocket costs; (2) reclassify benefits to increase costs; or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.</summary>
  <committee-reports/>
</bill>
